Clinical Trials Directory

Trials / Active Not Recruiting

Active Not RecruitingNCT06815523

Prediction of Duration of Mechanical Ventilation in Acute Hypoxemic Respiratoty Failure

Prediction of Duration of Mechanical Venylation in Patients Wit Acute Hypoxemic Respiratory Failure Usinf Machine Learning Approaches

Status
Active Not Recruiting
Phase
Study type
Observational
Enrollment
1,241 (actual)
Sponsor
Jesus Villar · Academic / Other
Sex
All
Age
18 Years
Healthy volunteers
Not accepted

Summary

Acute hypoxemic respiratory failure (AHRF) is a common cause of admission in intensive care units (ICUs) worldwide. We will assess machine learning (ML) techniques for prediction of prolonged duration (\> or = to 7 days) of mechanical ventilation (MV) in 1,241 patients enrolled in the PANDORA study in Spain. The study was registered with ClinalTrials.gov (NCT03145974). Our aim is to identify a model with the minimum number of variables that predict duration of prolonged ventilation in AHRF patients using data as early as from the first 48 hours with machine learning algorithms.

Detailed description

Acute hypoxemic respiratory failure (AHRF) is the most common cause of admission in intensive care units (ICUs) worldwide. The investigators will assess the value of machine learning (ML) techniques for prediction of prolonged duration (\> or equeal to 7 days) of mechanical ventilation (MV) in 1,241 patients enrolled in the PANDORA study in Spain. Few studies have investigated the prediction of prolonged MV in patients with AHRF. For model training and testing, the investigators will extract data from random pateints from the first 2 days after diagnosis of AHRF. The investigators had a database with 2,000,000 anonymized and dissociated demographics and clinically relevant data from 1,241 patients with AHRF from 22 hospitals in Spain. The investigators will follow the TRIPOD guidelines for prediction models. The investigators will screen relevant collected variables using a genetic algorithm variable selection to achieve parsimony. We will use 5-fold corss-validation in the data set of patients with data at T0, T24 and T48. We will use 25% of patients randomly selected for evaluation of the model.

Conditions

Interventions

TypeNameDescription
OTHERMachine learning and logistic regression for the training/testing cohort and validation cohortMachine learning and logistic regression for the validation cohort

Timeline

Start date
2025-02-02
Primary completion
2026-05-01
Completion
2026-06-01
First posted
2025-02-07
Last updated
2025-03-11

Locations

2 sites across 1 country: Spain

Source: ClinicalTrials.gov record NCT06815523. Inclusion in this directory is not an endorsement.